AAAAAA

   
Results: 1-11 |
Results: 11
PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION
Authors: GLUE P BANFIELD CR PERHACH JL MATHER GG RACHA JK LEVY RH
Citation: P. Glue et al., PHARMACOKINETIC INTERACTIONS WITH FELBAMATE - IN-VITRO IN-VIVO CORRELATION, Clinical pharmacokinetics, 33(3), 1997, pp. 214-224
SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF FELBAMATE IN THE ELDERLY
Authors: RICHENS A BANFIELD CR SALFI M NOMEIR A LIN CC JENSEN P AFFRIME MB GLUE P
Citation: A. Richens et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF FELBAMATE IN THE ELDERLY, British journal of clinical pharmacology, 44(2), 1997, pp. 129-134
THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING
Authors: BANFIELD CR ZHU GRR JEN JF JENSEN PK SCHUMAKER RC PERHACH JL AFFRIME MB GLUE P
Citation: Cr. Banfield et al., THE EFFECT OF AGE ON THE APPARENT CLEARANCE OF FELBAMATE - A RETROSPECTIVE ANALYSIS USING NONLINEAR MIXED-EFFECTS MODELING, Therapeutic drug monitoring, 18(1), 1996, pp. 19-29
EFFECT OF FELBAMATE ON VALPROIC ACID DISPOSITION IN HEALTHY-VOLUNTEERS - INHIBITION OF BETA-OXIDATION
Authors: HOOPER WD FRANKLIN ME GLUE P BANFIELD CR RADWANSKI E MCLAUGHLIN DB MCINTYRE ME DICKINSON RG EADIE MJ
Citation: Wd. Hooper et al., EFFECT OF FELBAMATE ON VALPROIC ACID DISPOSITION IN HEALTHY-VOLUNTEERS - INHIBITION OF BETA-OXIDATION, Epilepsia, 37(1), 1996, pp. 91-97
PHARMACOKINETIC VARIABILITY OF AMINOGLYCOSIDES - COMMENT
Authors: COLUCCI RD GLUE P BANFIELD CR RADWANSKI E
Citation: Rd. Colucci et al., PHARMACOKINETIC VARIABILITY OF AMINOGLYCOSIDES - COMMENT, The Annals of pharmacotherapy, 29(9), 1995, pp. 939-939
PHARMACOKINETIC PHARMACOKINETIC (PK-PD) MODELING FOR A NEW ANTIHYPERTENSIVE AGENT (NEUTRAL METALLOENDOPEPTIDASE INHIBITOR SCH-42354) IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION
Authors: FETTNER SH PAI S ZHU GR KOSOGLOU T BANFIELD CR BATRA V
Citation: Sh. Fettner et al., PHARMACOKINETIC PHARMACOKINETIC (PK-PD) MODELING FOR A NEW ANTIHYPERTENSIVE AGENT (NEUTRAL METALLOENDOPEPTIDASE INHIBITOR SCH-42354) IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, European Journal of Clinical Pharmacology, 48(5), 1995, pp. 351-359
EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF A LOW-DOSE COMBINATION ORAL-CONTRACEPTIVE
Authors: SAANO V GLUE P BANFIELD CR REIDENBERG P COLUCCI RD MEEHAN JW HARING P RADWANSKI E NOMEIR A LIN CC JENSEN PK AFFRIME MB
Citation: V. Saano et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF A LOW-DOSE COMBINATION ORAL-CONTRACEPTIVE, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 523-531
EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF THE MONOHYDROXY AND DIHYDROXY METABOLITES OF OXCARBAZEPINE
Authors: HULSMAN JARJ RENTMEESTER TW BANFIELD CR REIDENBERG P COLUCCI RD MEEHAN JW RADWANSKI E MOJAVERIAN P LIN CC NEZAMIS J AFFRIME MB GLUE P
Citation: Jarj. Hulsman et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF THE MONOHYDROXY AND DIHYDROXY METABOLITES OF OXCARBAZEPINE, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 383-389
EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF PHENOBARBITAL
Authors: REIDENBERG P GLUE P BANFIELD CR COLUCCI RD MEEHAN JW RADWANSKI E MOJAVARIAN P LIN CC NEZAMIS J GUILLAUME M AFFRIME MB
Citation: P. Reidenberg et al., EFFECTS OF FELBAMATE ON THE PHARMACOKINETICS OF PHENOBARBITAL, Clinical pharmacology and therapeutics, 58(3), 1995, pp. 279-287
COMMENT - WARFARIN-FELBAMATE INTERACTION
Authors: GLUE P BANFIELD CR COLUCCI RD PERHACH JL
Citation: P. Glue et al., COMMENT - WARFARIN-FELBAMATE INTERACTION, The Annals of pharmacotherapy, 28(12), 1994, pp. 1412-1413
IN-VIVO DETERMINATION OF ZERO-ORDER ABSORPTION FROM A TRANSDERMAL GLYCEROL TRINITRATE SYSTEM
Authors: CEFALI EA BANFIELD CR GONZALEZ MA WAGNER JG
Citation: Ea. Cefali et al., IN-VIVO DETERMINATION OF ZERO-ORDER ABSORPTION FROM A TRANSDERMAL GLYCEROL TRINITRATE SYSTEM, European journal of pharmaceutics and biopharmaceutics, 39(4), 1993, pp. 140-143
Risultati: 1-11 |